Page last updated: 2024-11-05

ochratoxin c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ochratoxin C (OTC) is a mycotoxin produced by various species of Aspergillus and Penicillium fungi. It is a structurally related compound to ochratoxin A (OTA), a known nephrotoxin and carcinogen, but with a different substitution on the isocoumarin moiety. While OTC has been reported to be less toxic than OTA, it still exhibits some biological activity. Limited research suggests potential cytotoxic effects and interference with cellular processes, but further investigation is needed to fully understand its toxicological significance. Its presence in food and feed can be a concern, particularly considering the potential for synergistic effects with other mycotoxins. OTC is studied to assess its potential risk to human and animal health and to develop strategies for its mitigation. The research aims to understand its biosynthesis, occurrence in food, and the mechanisms of its toxicity. This knowledge is crucial for implementing effective control measures and ensuring food safety.'

ochratoxin C: converted into ochratoxin A in vivo; RN given refers to (R)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ochratoxin C : A phenylalanine derivative that is the ethyl ester of ochratoxin A. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID20997
CHEBI ID141525
SCHEMBL ID455355
MeSH IDM0125606

Synonyms (27)

Synonym
ochratoxin c
ethyl (2s)-2-[[(3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoate
ethyl n-{[(3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1h-isochromen-7-yl]carbonyl}-l-phenylalaninate
CHEBI:141525
4865-85-4
ochratoxin a ethyl ester
ethyl (2s)-2-{[(3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1h-2-benzopyran-7-carbonyl]amino}-3-phenylpropanoate
ethyl n-[(3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1h-2-benzopyran-7-carbonyl]-l-phenylalaninate
unii-0dy21hw450
0dy21hw450 ,
alanine, n-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-, ethyl ester, l-
hsdb 3439
l-phenylalanine, n-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopyran-7-yl)carbonyl)-, ethyl ester, (r)-
l-phenylalanine, n-(((3r)-5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopyran-7-yl)carbonyl)-, ethyl ester
ochratoxin c [mi]
ochratoxin c [hsdb]
SCHEMBL455355
ethyl 2-([(5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1h-isochromen-7-yl)carbonyl]amino)-3-phenylpropanoate #
BPZZWRPHVVDAPT-PXAZEXFGSA-N
l-phenylalanine, n-[(5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopyran-7-yl)carbonyl]-, ethyl ester, (r)-
ethyl ((r)-5-chloro-8-hydroxy-3-methyl-1-oxoisochromane-7-carbonyl)-l-phenylalaninate
Q15633527
DTXSID00964097
CS-0093077
HY-125699
l-phenylalanine, n-[[(3r)-5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopyran-7-yl]carbonyl]-, ethyl ester
AKOS040753349

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" OTA is regarded as the most toxic family member, however, other ochratoxins or their metabolites and, in particular, ochratoxin mixtures or combinations with other mycotoxins may represent serious threats to human and animal health."( Comparative Ochratoxin Toxicity: A Review of the Available Data.
Bingle, LE; Heussner, AH, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
Aspergillus metaboliteAny fungal metabolite produced during a metabolic reaction in the mould, Aspergillus.
Penicillium metaboliteAny fungal metabolite produced during a metabolic reaction in Penicillium.
mycotoxinPoisonous substance produced by fungi.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
alpha-amino acid esterThe amino acid ester derivative obtained the formal condensation of an alpha-amino acid with an alcohol.
phenylalanine derivativeAn amino acid derivative resulting from reaction of alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of phenylalanine by a heteroatom. The definition normally excludes peptides containing phenylalanine residues.
isochromanes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.47 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]